NCT04103554View on ClinicalTrials.gov

Sacubitril/Valsartan in Left Ventricular Assist Device Recipients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Heart Failure
Interventions
DRUG

Sacubitril-Valsartan

Sacubitril-Valsartan 24/26 mg BID, 49/51 mg BID, 97/103 mg BID

DRUG

Standard of care

standard of care used for treating BP

Trial Locations (6)

10000

University Hospital Centre Zagreb, Zagreb

University Hospital Dubrava, Zagreb

Unknown

IKEM, Prague

University Medical Centre Utrecht, Utrecht

John Paul II Hospital, Krakow

3015 GD

Erasmus Medical Centre, Rotterdam

All Listed Sponsors
lead

University of Zagreb

OTHER